Tumor suppressors such as VHL, phosphatase and tensin homolog (PTEN), and liver kinase B1, which counteract the activity of these signaling pathways, are often epigenetically silenced in cancer, leading to their metabolic reprogramming.193, 194, 195. This evidence concerns the gene PTEN and cancer.